ArticleActa diabetologica2020

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study.

Yi-Chuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.